China Shineway Pharmaceutical Group Limited (FRA:C1S)
Germany · Delayed Price · Currency is EUR 1.020
-0.010 (-0.97%)
Last updated: Jan 27, 2026, 9:55 AM CET
FRA:C1S Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 828.24 | 840.05 | 969.51 | 722.77 | 556.67 | 295.03 |
Depreciation & Amortization | 61.99 | 68.74 | 60.23 | 185.86 | 182.39 | 208.41 |
Loss (Gain) From Sale of Assets | -4.01 | -4.01 | 2.39 | -0.13 | 16.47 | -2.06 |
Asset Writedown & Restructuring Costs | - | - | - | - | - | 229.6 |
Loss (Gain) From Sale of Investments | 6.61 | 6.61 | 5.44 | 8.83 | 7.02 | 6.92 |
Stock-Based Compensation | - | - | - | - | 0.03 | 0.13 |
Other Operating Activities | -149.45 | -170.21 | -128.19 | -97.6 | -102.65 | -137.53 |
Change in Accounts Receivable | 51.76 | 51.76 | -290.75 | -158.71 | -66.97 | -93.26 |
Change in Inventory | 169.97 | 169.97 | -123.18 | -69.7 | -140.13 | -12.2 |
Change in Accounts Payable | -80.12 | -80.12 | 176.05 | 80.13 | 55.39 | -25.07 |
Change in Unearned Revenue | -25.12 | -25.12 | -101.56 | 67.23 | 18.21 | 20.4 |
Change in Other Net Operating Assets | 105.47 | 105.47 | 362.69 | 370.99 | 176.71 | 148.2 |
Operating Cash Flow | 965.34 | 963.14 | 932.64 | 1,110 | 703.15 | 638.57 |
Operating Cash Flow Growth | -17.87% | 3.27% | -15.95% | 57.82% | 10.11% | 73.52% |
Capital Expenditures | -166.23 | -140.11 | -144.33 | -129.46 | -93.63 | -66.03 |
Sale of Property, Plant & Equipment | 13.24 | 4.71 | 12.9 | 2.58 | 81.6 | 26.2 |
Cash Acquisitions | - | - | - | - | 8.51 | -137.14 |
Divestitures | 2.34 | 2.34 | - | 0.92 | 0.88 | - |
Investment in Securities | 6.07 | -337.38 | 10.31 | 6.67 | 8.74 | 43.91 |
Other Investing Activities | 207.84 | 198.34 | 71.58 | 73.88 | 388.92 | -172.53 |
Investing Cash Flow | 63.26 | -272.11 | -49.54 | -45.42 | 395.01 | -305.59 |
Short-Term Debt Issued | - | 330 | 300 | - | - | 732.77 |
Total Debt Issued | 328.48 | 330 | 300 | - | - | 732.77 |
Short-Term Debt Repaid | - | -300 | - | - | -370.32 | -763 |
Long-Term Debt Repaid | - | -8.29 | -6.88 | -7.68 | -7.71 | -4.66 |
Total Debt Repaid | -338.46 | -308.29 | -6.88 | -7.68 | -378.03 | -767.66 |
Net Debt Issued (Repaid) | -9.99 | 21.71 | 293.13 | -7.68 | -378.03 | -34.89 |
Issuance of Common Stock | - | - | - | - | 3.66 | - |
Repurchase of Common Stock | - | - | - | - | - | -36.44 |
Common Dividends Paid | -355.04 | -407.92 | -317.27 | -241.73 | -453.07 | -173.56 |
Other Financing Activities | -9.28 | -6.27 | -2.6 | -0.63 | -1.49 | -16.99 |
Financing Cash Flow | -374.31 | -392.48 | -26.74 | -250.04 | -828.94 | -329.79 |
Foreign Exchange Rate Adjustments | -28.44 | -47.17 | 6.15 | 6.33 | -6.51 | -6.18 |
Net Cash Flow | 625.85 | 251.38 | 862.51 | 820.54 | 262.71 | -3 |
Free Cash Flow | 799.11 | 823.02 | 788.31 | 980.21 | 609.52 | 572.54 |
Free Cash Flow Growth | -20.54% | 4.40% | -19.58% | 60.82% | 6.46% | 104.77% |
Free Cash Flow Margin | 23.90% | 21.78% | 17.45% | 24.81% | 18.91% | 21.56% |
Free Cash Flow Per Share | 1.06 | 1.09 | 1.04 | 1.30 | 0.81 | 0.76 |
Cash Interest Paid | 9.28 | 6.27 | 2.6 | 0.63 | 1.49 | 16.99 |
Cash Income Tax Paid | 246.4 | 246.4 | 224.14 | 136.3 | 132.32 | 96.15 |
Levered Free Cash Flow | 555.68 | 564.33 | 484.47 | 827.13 | 776.83 | 102.34 |
Unlevered Free Cash Flow | 561.39 | 568.16 | 486.18 | 827.52 | 777.61 | 112.71 |
Change in Working Capital | 221.96 | 221.96 | 23.25 | 289.94 | 43.21 | 38.07 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.